Search clinical trials for: Progressive Androgen-Independent Prostate Cancer
Total 89551 results
-
Nazmy Edward SeifRecruitingProstate Cancer | Surgery | Urinary Bladder Cancer | Positive End Expiratory Pressure | Lung UltrasoundEgypt
-
University of California, DavisNational Cancer Institute (NCI)RecruitingRenal Cell Carcinoma | Oligoprogressive | Prostate Cancer | Urothelial CarcinomaUnited States
-
University of ArkansasRecruitingCastration Sensitive Prostate CancerUnited States
-
Novartis PharmaceuticalsRecruitingMetastatic Castration-Resistant Prostate Cancer (mCRPC)Spain, France
-
MacroGenicsRecruitingProstate Cancer Recurrent | Immunotherapy | Androgen-Independent Prostatic Cancer | Androgen-Resistant Prostatic Cancer | Hormone Refractory Prostatic Cancer | Immune Checkpoint Inhibitor | Androgen-Independent Prostatic Neoplasms | Androgen-Insensitive Prostatic Cance | Inhibitory Checkpoint MoleculeUnited States, Spain, France, Belgium, United Kingdom, Poland, Georgia, Bulgaria, Puerto Rico, Australia
-
Weill Medical College of Cornell UniversityMerck Sharp & Dohme LLC; United States Department of DefenseRecruiting
-
Weill Medical College of Cornell UniversityRecruiting
-
Dana-Farber Cancer InstituteNational Institute on Aging (NIA)Recruiting
-
VA Office of Research and DevelopmentMerck Sharp & Dohme LLCRecruitingMetastatic Castration Resistant Prostate CancerUnited States
-
Merck Sharp & Dohme LLCRecruitingMetastatic Castration-Resistant Prostate CancerUnited States, Austria, Canada, France, Germany, Ireland, Italy, Mexico, Netherlands, New Zealand, Poland, Russian Federation, Sweden, Taiwan, Turkey, Ukraine, United Kingdom, Spain, Finland, Australia, Denmark
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); GlaxoSmithKline; Genentech, Inc.; Brain Science...RecruitingIntracranial Meningioma | Recurrent Meningioma | NF2 Gene MutationUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingProstate CancerUnited States
-
Novartis PharmaceuticalsActive, not recruitingMetastatic Castration-Resistant Prostate Cancer (mCRPC)China
-
Astellas Pharma IncActive, not recruitingProgressive Metastatic Prostate CancerChina, Hong Kong, Korea, Republic of, Taiwan
-
MacroGenicsActive, not recruitingMelanoma | Non-small Cell Lung Cancer | Small-cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Anal Cancer | Malignant Melanoma | Non-small Cell Carcinoma | Oral Squamous Cell Carcinoma | Small Cell Carcinoma | Laryngeal Squamous Cell Carcinoma | Carcinoma, Squamous Cell of Head and Neck | Castration-Resistant... and other conditionsSpain, Australia, United States, Korea, Republic of, France, United Kingdom, Italy, Belgium, Poland
-
AvenCell Europe GmbHPHARMALOG Institut für klinische Forschung GmbHTerminated
-
Astellas Pharma IncCompletedMetastatic Castration Resistant Prostate CancerIndia
-
Novartis PharmaceuticalsActive, not recruitingMetastatic Castration-Resistant Prostate Cancer (mCRPC)China
-
Novartis PharmaceuticalsActive, not recruitingProstatic NeoplasmsBelgium, Canada, Spain, Germany, Austria, Netherlands, United Kingdom, United States, France, Switzerland, Sweden, Slovakia, Poland, Czechia
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityTerminatedPrimary Myelofibrosis | Anemia | Recurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Anatomic Stage IV Breast Cancer AJCC v8 | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic... and other conditionsUnited States
-
Lantheus Medical ImagingPOINT BiopharmaAvailableCastration-Resistant Prostatic CancerUnited States
-
Immunic AGTerminatedMetastatic Castration Resistant Prostate CancerUnited Kingdom
-
Progenics Pharmaceuticals, Inc.Active, not recruitingCastration-resistant Prostate Cancer | Metastatic Prostate Cancer | Cancer of the Prostate | Prostatic Neoplasm | Progressive mCRPCUnited States, Canada
-
Weill Medical College of Cornell UniversityActive, not recruitingProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterBristol-Myers Squibb; Northwestern University; Oregon Health and Science UniversityActive, not recruiting
-
Weill Medical College of Cornell UniversityPOINT BiopharmaSuspendedProstate CancerUnited States
-
AstraZenecaParexelCompletedProgressive Metastatic Castrate-Resistant Prostate CancerUnited States, Spain, Belgium, France, Korea, Republic of
-
AvenCell Europe GmbHGCP-Service International Ltd. & Co. KGTerminatedTransitional Cell Carcinoma | Prostate Cancer | Non-small Cell Lung Cancer | Renal CancerGermany
-
Memorial Sloan Kettering Cancer CenterAragon Pharmaceuticals, Inc.Completed
-
Jonsson Comprehensive Cancer CenterNovartis; Stand Up To Cancer; Prostate Cancer FoundationActive, not recruitingMetastatic Prostate Carcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Resistant Prostate CancerUnited States
-
Cancer Trials IrelandTerminatedMetastatic Cancer | Bone Metastases | Castration-resistant Prostate CancerIreland
-
Advanced Accelerator ApplicationsTerminatedProstatic NeoplasmUnited States, Spain
-
Astellas Pharma IncMedivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedProstatic NeoplasmsUnited States, Belgium, Canada, Denmark, France, Germany, Romania, United Kingdom
-
National Cancer Institute (NCI)TerminatedProstate Neoplasms | Metastatic Castration Resistant Prostate CancerUnited States
-
Australian and New Zealand Urogenital and Prostate...Endocyte; Movember Foundation; Australian Nuclear Science and Technology Organisation... and other collaboratorsCompletedMetastatic Cancer | Cancer of the ProstateAustralia
-
Northwestern UniversityNational Cancer Institute (NCI); Vasgene Therapeutics, IncActive, not recruitingProgressive Disease | Castration-Resistant Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8 | PSA Progression | Metastatic Prostate Adenocarcinoma | Castration Levels of Testosterone | Prostate Carcinoma Metastatic in the Bone | Castration-Resistant Prostate Carcinoma Refractory to Second-Generation... and other conditionsUnited States
-
Stanford UniversityActive, not recruitingAcute Myeloid Leukemia | Stage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Progressive Disease | Myelodysplastic Syndrome | Stage IIA Rectal Cancer | Stage IIB Rectal Cancer | Stage IIC Rectal Cancer | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer and other conditionsUnited States
-
Universität des SaarlandesCompleted
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedProstate CancerCanada, United States, Spain, Australia, Denmark, Korea, Republic of, Belgium, Singapore, Finland, Netherlands, France, Austria, Germany, Israel, United Kingdom, Italy, Japan, Lithuania, Poland, Russian Federation, Slovakia, Sweden
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Regeneron Pharmaceuticals; Prostate Cancer FoundationWithdrawnStage III Prostate Cancer | Stage IV Prostate Cancer | Stage IVA Prostate Cancer | Stage IVB Prostate Cancer | Stage IIIA Prostate Cancer | Stage IIIB Prostate Cancer | Stage IIIC Prostate Cancer
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI); The Wayne D. Kuni and Joan E. Kuni FoundationTerminatedProstate Adenocarcinoma | Recurrent Prostate Carcinoma | Metastatic Prostatic Adenocarcinoma | Hormone-Resistant Prostate CancerUnited States
-
Tampere University HospitalVaralan urheiluopistoUnknown
-
University of California, San FranciscoNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Swiss Group for Clinical Cancer ResearchCompleted
-
Jonsson Comprehensive Cancer CenterNovartisNo longer availableProgressive Metastatic Castrate Resistant Prostate Cancer
-
Duke UniversityUnited States Department of Defense; Prostate Cancer Foundation; Janssen Diagnostics...CompletedMetastatic Progressive Castration-resistant Prostate Cancer | Metastatic Progressive Breast CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedProstate Cancer | Metastatic CancerUnited States
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedMetastatic Progressive Castration-resistant Prostate CancerUnited States
-
Astellas Pharma Europe B.V.Medivation, Inc.CompletedProstate Cancer | Castration-Resistant Prostate CancerRussian Federation, Georgia
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)TerminatedProstate CancerUnited States